PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study

PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study

Activating synthetic ligands for peroxisome proliferator-activated receptor gamma (PPARγ), such as pioglitazone, are commonly used to treat persons with diabetes mellitus with improvement of insulin resistance. Several reports have clearly demonstrated that PPARγ ligands could inhibit colorectal can...

Full description

Saved in:
Bibliographic Details
Main Authors: Hirokazu Takahashi, Kunihiro Hosono, Takashi Uchiyama, Michiko Sugiyama, Eiji Sakai, Hiroki Endo, Shin Maeda, Katherine L. Schaefer, Hitoshi Nakagama, Atsushi Nakajima
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:PPAR Research
Online Access:http://dx.doi.org/10.1155/2010/257835
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items